SQZ Biotechnologies Reports Full Year 2021 Financial Results and Recent Portfolio Updates
16.03.2022 - SQZ Biotechnologies (NYSE: SQZ), focused on unlocking the full potential of cell therapies for multiple therapeutic areas, today reported full year 2021 financial results and recent portfolio updates. “We have much to be proud of as 2021 was a year ...
Patrick Vink Bernard Coulie John Maraganore Exchange Commission Federation Of Clinical Immunology Societies Society For Immunotherapy Of Cancer
Source: wallstreet-online.de